Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Change in Account Payables (2016 - 2025)

Dare Bioscience's Change in Account Payables history spans 11 years, with the latest figure at -$621272.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 252.59% year-over-year to -$621272.0; the TTM value through Dec 2025 reached -$255146.0, up 86.78%, while the annual FY2025 figure was -$255146.0, 86.78% up from the prior year.
  • Change in Account Payables reached -$621272.0 in Q4 2025 per DARE's latest filing, down from $518208.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.8 million in Q2 2023 to a low of -$2.1 million in Q2 2024.
  • Average Change in Account Payables over 5 years is $9439.7, with a median of $389689.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: plummeted 787.67% in 2021, then soared 506.37% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at $1.5 million in 2021, then crashed by 196.79% to -$1.4 million in 2022, then fell by 10.53% to -$1.6 million in 2023, then skyrocketed by 125.42% to $407154.0 in 2024, then crashed by 252.59% to -$621272.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Change in Account Payables are -$621272.0 (Q4 2025), $518208.0 (Q3 2025), and -$152082.0 (Q2 2025).